How this ASU spinout is making fighting cancer personal

“Once we saw the potential of the difference it could make, we all felt obligated that we had to do something,” said David Richardson, co-founder and CEO of bioSyntagma LLC, a spinout of ASU. “If we didn’t do anything with the idea and make it a business, it would help no one.”

Leave a Reply

Your email address will not be published. Required fields are marked *

*

*